| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	
																	
																	
																	
																	
																	
																	
																	
																	Regencell Bioscience (NASDAQ:RGC) reported quarterly losses of $(0.36) per share. This is a 14.29 percent increase over losses ...